nanovis
-
Nanovis Awarded Nanotechnology Designation for Bioceramic Nanotube Surface
CARMEL, IND. (PRWEB) OCTOBER 23, 2019 Nanovis today announced that it received the first 510(k) clearance for a bioceramic nanotube surface…
Read More » -
Nanovis Announces Commercial Launch of New Nanosurface Technology on Spinal Interbody Implants
CARMEL, IND. (PRWEB) AUGUST 01, 2019 Nanovis today announced the commercial launch of its bioceramic nanotube enhanced FortiCore interbodies following a successful…
Read More » -
Nanovis Named MedTech Outlook Top 10 Orthopedic Solution Provider, 2019
CARMEL, IND. (PRWEB) MAY 08, 2019 Nanovis today announced that MedTech Outlook recognized Nanovis as a Top 10 Orthopedic Solution Provider, 2019.…
Read More » -
Nanovis Wins the Global Health & Pharma 2018 Technology Awards
CARMEL, IND. (PRWEB) FEBRUARY 05, 2019 Nanovis today announced that Global Health & Pharma magazine recognized Nanovis as the Best Nanotechnology Driven…
Read More » -
Nanovis Expands the Range of Footprints for its Signature FortiCore Posterior Lumbar Interbody Fusion System
CARMEL, IND. (PRWEB) NOVEMBER 14, 2018 Nanovis, a leader in nanomedicine for the spine, today announced adding 22mm and 25mm lengths…
Read More » -
Nanovis Licenses Key Nanosurface Technology Patent from the University of Nevada, Reno
CARMEL, IND. (PRWEB) SEPTEMBER 11, 2018 Nanovis, a leader in nanomedicine for the spine, today announced a licensing agreement with the…
Read More » -
Nanovis Announces Successful Completion of $5.5 Million Investment Round To Fund Technology-Driven Growth
CARMEL, IND. (PRWEB) AUGUST 28, 2018 Nanovis, an innovative and fast-growing technology company selling nano-technology enhanced spinal implants, announced today the…
Read More » -
Nanovis Announces FDA Clearance of FortiCore® PLIF and TLIF Spinal Interbodies with Nanosurface Features
Carmel, Ind. (March 28, 2018) – Nanovis, today announced the successful FDA clearance of its FortiCore® TLIF and PLIF interbodies…
Read More » -
Nanovis announces a Successful Alpha Launch of the FortiCore® PLIF and the 2,000th FortiCore® Interbody Implantation.
Carmel and Columbia City, Ind. (February 16, 2017) – Nanovis, a life sciences company committed to developing implant systems that…
Read More » -
National Institutes of Health Awards Second Research Grant to Nanovis
Nanovis’ Deeply Porous Spinal Implants with Nanotube-Enhanced Surfaces May Significantly Improve Patient Recovery from Spinal Fusion Procedures Carmel, Ind. (March 8,…
Read More » -
Nanovis Launches Expanded FortiCore Line of Interbody Fusion Devices at NASS
CARMEL, Ind., Oct. 15, 2015 /PRNewswire/ — Nanovis, a life sciences company committed to developing scientifically advanced regenerative platforms for implantable medical devices,…
Read More » -
Nanovis Spine, LLC receives FDA 510(k) clearance of its FortiBridge cervical plating system designed to complement the FortiCore® cervical interbody fusion device platform
Nanovis Spine, LLC receives FDA 510(k) clearance of its FortiBridgeTM cervical plating system designed to complement the FortiCore® cervical interbody…
Read More » -
Nanovis Spine, LLC receives FDA 510(k) clearance of its novel FortiCoreTM cervical and lumbar interbody fusion device platform
Carmel, Ind. (September 22, 2014) – Nanovis Spine, LLC (Nanovis) announced today that it has received U.S. Food and Drug…
Read More »